Michael P Dube, MD

Title(s)Professor of Research Medicine (Part- Time)
SchoolKeck School of Medicine of Usc
AddressGNH 5P2 349
Health Sciences Campus
Los Angeles CA 90089-9316
Phone+1 323 409 8288
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Dubé is an attending physician at the Los Angeles County-USC Medical Center in Los Angeles. He is the Associate Director of the 5P21 Rand Schrader Health and Research Center at LA County-USC Medical Center. Dr. Dubé is also a Professor of Medicine at USC's Keck School of Medicine.

    Dr. Dubé earned his medical degree from Boston University School of Medicine. He then went on to complete his internship, residency and fellowship at LAC+USC Medical Center, specializing in Infectious Diseases.

    Collapse Research 
    Collapse Research Activities and Funding
    Microbial Translocation and HIV-Related Endothelial Dysfunction
    NIH R21AI091492Sep 16, 2010 - Aug 31, 2013
    Role: Principal Investigator
    Endothelial Dysfunction Due to HIV-1 Protease Inhibitors
    NIH R01HL072711Sep 30, 2002 - Jul 31, 2009
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s. Clin Infect Dis. 2022 03 09; 74(5):857-864. Koethe JR, Moser C, Brown TT, Stein JH, Kelesidis T, Dube M, Currier J, McComsey GA. PMID: 34117756; PMCID: PMC8906713.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    2. A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open Forum Infect Dis. 2021 Dec; 8(12):ofab550. Presti RM, Yeh E, Williams B, Landay A, Jacobson JM, Wilson C, Fichtenbaum CJ, Utay NS, Dube MP, Klingman KL, Estes JD, Flynn JK, Loftin A, Brenchley JM, Andrade A, Kitch DW, Overton ET. PMID: 34888397; PMCID: PMC8651169.
      View in: PubMed   Mentions: 3  
    3. The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. AIDS Rev. 2021 02 08; 23(1):40-47. Griffin DO, Brennan-Rieder D, Ngo B, Kory P, Confalonieri M, Shapiro L, Iglesias J, Dube M, Nanda N, In GK, Arkfeld D, Chaudhary P, Campese VM, Hanna DL, Sawcer D, Ehresmann G, Peng D, Smorgorzewski M, Amstrong A, Vinjevoll EH, Dasgupta R, Sattler FR, Mussini C, Mitjà O, Soriano V, Peschanski N, Hayem G, Piccirillo MC, Lobo-Ferreira A, Rivero IB, Hung IFH, Rendell M, Ditmore S, Varon J, Marik P. PMID: 33556957.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    4. Greater Levels of Self-Reported Adherence to Pre-Exposure Prophylaxis (PrEP) are Associated with Increased Condomless Sex Among Men Who Have Sex with Men. AIDS Behav. 2020 Nov; 24(11):3192-3204. Pasipanodya EC, Li MJ, Jain S, Sun X, Tobin J, Ellorin E, Dube M, Daar ES, Corado K, Milam J, Blumenthal J, Morris SH, Moore DJ, and the California Collaborative Treatment Group (CCTG). PMID: 32350774; PMCID: PMC7508761.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    5. Characteristics of a cohort of high-risk men who have sex with men on pre-exposure prophylaxis reporting transgender sexual partners. Medicine (Baltimore). 2019 Dec; 98(50):e18232. Hassan A, Wertheim JO, Blumenthal JS, Ellorin E, Dube MP, Corado K, Moore DJ, Morris SR. PMID: 31852085; PMCID: PMC6922495.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    6. Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men. AIDS Patient Care STDS. 2019 05; 33(5):220-226. Blumenthal J, Moore DJ, Jain S, Sun X, Ellorin E, Corado K, Hoenigl M, Dube M, Haubrich R, Morris SR. PMID: 31067122; PMCID: PMC6531901.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    7. Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex With Men. J Infect Dis. 2018 10 05; 218(10):1551-1559. Pasipanodya EC, Jain S, Sun X, Blumenthal J, Ellorin E, Corado K, Dube MP, Daar ES, Morris SR, Moore DJ, California Collaborative Treatment Group (CCTG) TAPIR Study Team. PMID: 30295803; PMCID: PMC6455933.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    8. Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594. AIDS Behav. 2018 Aug; 22(8):2698-2710. Corado K, Jain S, Morris S, Dube MP, Daar ES, He F, Aldous JL, Sitapati A, Haubrich R, Milam J, Karris MY. PMID: 29725790; PMCID: PMC6599592.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):362-366. Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT. PMID: 29533303; PMCID: PMC5997510.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis. Sex Transm Infect. 2018 11; 94(7):508-514. Hassan A, Blumenthal JS, Dube MP, Ellorin E, Corado K, Moore DJ, Morris SR. PMID: 29907624; PMCID: PMC6586483.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    11. Tenofovir Disoproxil Fumarate-Associated Fanconi Syndrome in an Human Immunodeficiency Virus (HIV)-Uninfected Man Receiving HIV Pre-Exposure Prophylaxis. Open Forum Infect Dis. 2017; 4(3):ofx149. Khan S, Funk CA, Corado K, Morris S, Dube MP. PMID: 30591921; PMCID: PMC6300303.
      View in: PubMed   Mentions:
    12. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 May 15; 64(10):1422-1429. Lake JE, Stanley TL, Apovian CM, Bhasin S, Brown TT, Capeau J, Currier JS, Dube MP, Falutz J, Grinspoon SK, Guaraldi G, Martinez E, McComsey GA, Sattler FR, Erlandson KM. PMID: 28329372; PMCID: PMC5411395.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    13. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS. 2016 11 13; 30(17):2625-2633. Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS. PMID: 27603288; PMCID: PMC5083154.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    14. Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s. Antivir Ther. 2017; 22(2):113-126. Kelesidis T, Tran TTT, Brown TT, Moser C, Ribaudo HJ, Dube MP, Yang OO, McComsey GA, Stein JH, Currier JS. PMID: 27661466; PMCID: PMC5364070.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    15. Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016 Sep; 3(3):ofw174. Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA. PMID: 27704026; PMCID: PMC5047417.
      View in: PubMed   Mentions: 18  
    16. Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. J Infect Dis. 2016 09 01; 214(5):748-52. Kelesidis T, Moser C, Stein JH, Brown TT, Tran TT, Ribaudo HJ, Dube MP, Yang OO, Currier JS, McComsey GA. PMID: 27354367; PMCID: PMC4978379.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    17. Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. J Acquir Immune Defic Syndr. 2016 06 01; 72(2):133-7. Dan JM, Massanella M, Smith DM, Spina CA, Schrier R, Daar ES, Dube MP, Morris SR, Gianella S. PMID: 26818740; PMCID: PMC4868660.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    18. Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue. J Acquir Immune Defic Syndr. 2016 06 01; 72(2):e48-50. Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S, California Collaborative Treatment Group (CCTG) 589 Study Team. PMID: 26977746; PMCID: PMC4867124.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy. BMC Infect Dis. 2016 Jan 25; 16:24. Gianella S, Ginocchio CC, Daar ES, Dube MP, Morris SR. PMID: 26809559; PMCID: PMC4727320.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    20. Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection. AIDS. 2016 Jan; 30(2):193-201. Vanpouille C, Introini A, Morris SR, Margolis L, Daar ES, Dube MP, Little SJ, Smith DM, Lisco A, Gianella S. PMID: 26558730; PMCID: PMC4862605.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    21. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS. 2015 Sep 10; 29(14):1775-83. Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, Brodell EL, Kelesidis T, McComsey GA, Dube MP, Murphy RL, Currier JS. PMID: 26372383; PMCID: PMC4571277.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCellsCTClinical Trials
    22. Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep. 2015 Aug 24; 5:13179. Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR. PMID: 26299251; PMCID: PMC4547398.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    23. Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men. PLoS One. 2015; 10(6):e0130410. Gianella S, Smith DM, Daar ES, Dube MP, Lisco A, Vanpouille C, Margolis L, Haubrich RH, Morris SR. PMID: 26061824; PMCID: PMC4465639.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    24. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clin Infect Dis. 2015 Aug 15; 61(4):651-60. Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA. PMID: 25904376; PMCID: PMC4542595.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    25. Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J Virol. 2014 Jul; 88(14):7818-27. Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM, California Collaborative Treatment Group 592 Team. PMID: 24789781; PMCID: PMC4097769.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    26. Factors associated with high transmission risk and detectable plasma HIV RNA in HIV-infected MSM on ART. Int J STD AIDS. 2014 Sep; 25(10):734-41. Blumenthal J, Haubrich R, Jain S, Sun X, Dube M, Daar E, Milam J, Morris S. PMID: 24452730; PMCID: PMC4303352.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    27. Virologic correlates of anti-CMV IgG levels in HIV-1-infected men. J Infect Dis. 2014 Feb 01; 209(3):452-6. Gianella S, Morris SR, Tatro E, Vargas MV, Haubrich RH, Daar ES, Dube MP, Richman DD, Little SJ, Smith DM. PMID: 23964106; PMCID: PMC3883163.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    28. Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1293-9. Hulgan T, Stein JH, Cotter BR, Murdock DG, Ritchie MD, Dube MP, Gerschenson M, Haas DW, Torriani FJ, Aids Clinical Trials Group A5152s And Dacs 252 Study Teams. PMID: 23944767; PMCID: PMC3785797.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    29. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis. 2013 Nov; 57(10):1483-8. Grant PM, Kitch D, McComsey GA, Dube MP, Haubrich R, Huang J, Riddler S, Tebas P, Zolopa AR, Collier AC, Brown TT. PMID: 23943825; PMCID: PMC3805172.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    30. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis. 2013 Aug; 57(3):441-7. Gianella S, Smith DM, Vargas MV, Little SJ, Richman DD, Daar ES, Dube MP, Zhang F, Ginocchio CC, Haubrich RH, Morris SR, CCTG 592 Team. PMID: 23595831; PMCID: PMC3703105.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    31. Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent. Pharmacogenomics J. 2014 Apr; 14(2):160-70. Aminkeng F, Ross CJ, Rassekh SR, Brunham LR, Sistonen J, Dube MP, Ibrahim M, Nyambo TB, Omar SA, Froment A, Bodo JM, Tishkoff S, Carleton BC, Hayden MR, Canadian Pharmacogenomics Network for Drug Safety Consortium. PMID: 23588107; PMCID: PMC4684079.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    32. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy. AIDS. 2010 Mar 27; 24(6):885-90. Murphy RL, Berzins B, Zala C, Fichtenbaum C, Dube MP, Guaraldi G, Torriani F, Belsey E, Mitchell C, Stein JH, SABAR Study Team. PMID: 19952712.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    33. Genetic analysis implicates resistin in HIV lipodystrophy. AIDS. 2008 Aug 20; 22(13):1561-8. Ranade K, Geese WJ, Noor M, Flint O, Tebas P, Mulligan K, Powderly W, Grinspoon SK, Dube MP. PMID: 18670214; PMCID: PMC4410015.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    34. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis. 2006 Sep 01; 43(5):645-53. Wohl DA, McComsey G, Tebas P, Brown TT, Glesby MJ, Reeds D, Shikuma C, Mulligan K, Dube M, Wininger D, Huang J, Revuelta M, Currier J, Swindells S, Fichtenbaum C, Basar M, Tungsiripat M, Meyer W, Weihe J, Wanke C. PMID: 16886161.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    35. Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med. 2006 Mar; 3(3):e52. Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, Reilly MP. PMID: 16417409; PMCID: PMC1334223.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    36. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s. AIDS. 2004 Dec 03; 18(18):2434-7. Henry K, Kitch D, Dube M, Zackin R, Parker RA, Sprecher D, Hammer S, Currier J, Adult AIDS Clinical Trials Group. PMID: 15622323.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    37. Probiotics, soluble fiber, and L-Glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea. J Int Assoc Physicians AIDS Care (Chic). 2004 Oct-Dec; 3(4):121-9. Heiser CR, Ernst JA, Barrett JT, French N, Schutz M, Dube MP. PMID: 15768732.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    38. Lipid abnormalities. Clin Infect Dis. 2003 Apr 01; 36(Suppl 2):S79-83. Dube M, Fenton M. PMID: 12652375.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    39. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. J Infect Dis. 2003 Apr 01; 187(7):1046-52. Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani FJ, Lennox JL, Dube MP, MacGregor RR, Currier JS, AIDS Clinical Trial Group 393 Study Team. PMID: 12660918.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    40. Elevated blood pressure in subjects with lipodystrophy. AIDS. 2001 Oct 19; 15(15):2001-10. Sattler FR, Qian D, Louie S, Johnson D, Briggs W, DeQuattro V, Dube MP. PMID: 11600829.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    41. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab. 1999 Apr; 84(4):1268-76. Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP, Martinez C, Briggs W, Horton R, Azen S. PMID: 10199766.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    42. Metabolic complications of antiretroviral therapies. AIDS Clin Care. 1998 Jun; 10(6):41-4. Dube MP, Sattler FR. PMID: 11365497.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa: comparison of karyotype and restriction fragment length polymorphisms. J Clin Microbiol. 1996 Jun; 34(6):1494-6. Dib JC, Dube M, Kelly C, Rinaldi MG, Patterson JE. PMID: 8735104; PMCID: PMC229048.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    44. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med. 1994 Dec 15; 121(12):905-11. Chaisson RE, Benson CA, Dube MP, Heifets LB, Korvick JA, Elkin S, Smith T, Craft JC, Sattler FR. PMID: 7978715.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    45. Effects of hyperthyroidism and hypothyroidism on human red blood cell Ca2+-ATPase activity. J Clin Endocrinol Metab. 1986 Feb; 62(2):253-7. Dube MP, Davis FB, Davis PJ, Schoenl M, Blas SD. PMID: 2934403.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Michael's Networks
    Concepts (225)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (37)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.